Physician profile
Bryce St Clair
NPI 1306495031
$7,840.04
in general payments reported to CMS, 2019-2025
24 companies · $1,135 in 2025
The $1,135 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $141 · 2021: $117 · 2022: $1,115 · 2023: $2,239 · 2024: $2,604 · 2025: $1,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,909 · Consulting Fee: $1,660 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,909.19 |
| Consulting Fee | $1,660.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $410.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,019.43 | 2022-2025 | Total30, Dailies Total1, Precision 1 |
| Tarsus Pharmaceuticals, INC. | $1,844.30 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $587.79 | 2022-2025 | Cequa |
| Horizon Therapeutics Plc | $577.85 | 2022-2023 | Tepezza |
| Dompe US, INC. | $405.02 | 2021-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $371.47 | 2022-2025 | Miebo, Xiidra |
| Lkc Technologies, INC. | $277.57 | 2024-2025 | |
| Johnson & Johnson Vision Care, INC. | $250.71 | 2022-2025 | Acuvue |
| Emd Serono, INC. | $216.96 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $161.99 | 2019-2020 | |
| Abbvie INC. | $147.93 | 2023 | Durysta, Vuity |
| Allergan, INC. | $119.65 | 2022 | |
| Mallinckrodt Hospital Products INC. | $112.90 | 2024 | Acthar |
| Optos, INC. | $110.08 | 2022 | |
| Biotissue Holdings INC. | $106.49 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $96.70 | 2020 | |
| Harrow Eye, LLC | $90.42 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $88.20 | 2022 | |
| Carl Zeiss Meditec, INC. | $86.67 | 2019 | |
| Rxsight INC | $75.00 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Spark Therapeutics, INC. | $29.41 | 2019 | |
| Coopervision INC. | $26.52 | 2023 | Myday Contact Lens |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Glaukos Corporation | $17.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce St Clair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.